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The Generalized Po´lya Urn (GPU) is a popular urn model which
is widely used in many disciplines. In particular, it is extensively used
in treatment allocation schemes in clinical trials. In this paper, we
propose a sequential estimation-adjusted urn model (a nonhomoge-
neous GPU) which has a wide spectrum of applications. Because the
proposed urn model depends on sequential estimations of unknown
parameters, the derivation of asymptotic properties is mathemati-
cally intricate and the corresponding results are unavailable in the
literature. We overcome these hurdles and establish the strong con-
sistency and asymptotic normality for both the patient allocation and
the estimators of unknown parameters, under some widely satisfied
conditions. These properties are important for statistical inferences
and they are also useful for the understanding of the urn limiting
process. A superior feature of our proposed model is its capability
to yield limiting treatment proportions according to any desired al-
location target. The applicability of our model is illustrated with a
number of examples.
1. Introduction.
1.1. Brief history. Urn models have long been recognized as valuable
mathematical apparatus in many areas including physical sciences, biological
sciences and engineering [19, 20]. Among various urn models, the Po´lya urn
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(also known as the Po´lya–Eggenberger urn) model is particularly popular.
It was originally proposed to model the problem of contagious diseases [10].
Since then, there have been numerous generalizations and extensions. For
example, in information science, Martin and Ho [21] apply the Po´lya urn
process to study human decision-making. In population genetics, Bena¨im,
Schreiber and Tarre´s [9] make use of a class of generalized Po´lya urn models
to scrutinize the evolutionary processes. In economics, the model is employed
to capture the mechanism of reinforcement learning by Erev and Roth [13]
and Beggs [8]. In business, a coupled Po´lya urn model is utilized by Windrum
[32] to examine the recent browser war between Netscape and Microsoft.
Urn models are also extensively applied in clinical studies. Applications
are mostly found in the area of adaptive design in which urn models are uti-
lized to provide response-adaptive allocation schemes. In most clinical trials,
patients accrue sequentially. Assume the availability of several treatments.
Adaptive designs are valuable and ethical randomization schemes that for-
mulate treatment allocation as a function of previous responses, with one of
the important objectives to assign more patients to the better treatment.
Early works in adaptive design can be traced to Thompson [29] and
Robbins [24]. Athreya and Karlin [3] successfully embed the urn schemes into
a continuous-time branching process and generate important limit theorems.
Among many useful allocation schemes generated under the paradigm of urn
models, the most influential family of models is the Generalized Po´lya Urn
(GPU) [also named as the Generalized Friedman’s Urn (GFU) in literature]
[2, 3, 30].
A general description of the GPU model is as follows. To compareK treat-
ments in a clinical study, consider an urn containing particles of K types,
representing theK treatments. Patients arrive sequentially to be allocated to
the treatments. At the beginning, the urn contains Y0 = (Y0,1, . . . , Y0,K) par-
ticles, where Y0,k > 0 denotes the number of particles of type k, k = 1, . . . ,K.
At stage i, i = 1,2, . . . , a particle is drawn from the urn and replaced. If
the particle is of type k, then treatment k is assigned to the ith patient,
k = 1, . . . ,K, i= 1,2, . . . . After observing a random variable ξi,k which rep-
resents the response of the ith patient on treatment k, additional di(k, g, ξi,k)
particles of type g, g = 1, . . . ,K, are added to the urn, where di(k, g, ξi,k) is
a function of ξi,k. After n splits and generations, the urn composition is
denoted by the row vector Yn = (Yn,1, . . . , Yn,K), where Yn,k stands for the
number of particles of type k in the urn after the nth split. The urn com-
position in stage n can be characterized by the following recursive formula:
Yn =Yn−1 +XnDn,(1.1)
where the matrix Dn = (dn(k, g, ξn,k), k, g = 1, . . . ,K) and Xn = (Xn,1, . . . ,
Xn,K) is the observed result of the nth draw, distributed according to the
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urn composition at the previous stage. That is, if the nth draw is a type-k
particle, all elements in Xn are 0 except the kth component Xn,k which is 1.
Moreover, defineHi = (E[di(k, g, ξi,k)|Fi−1], k, q = 1, . . . ,K), where the sigma
field Fi is generated by {Y0,Y1, . . . ,Yi,X1, . . . ,Xi}. The matrices Di and
Hi are called the addition rules and the generating matrices, respectively.
These matrices play important roles in the mechanism of the GPU model.
A GFU model is said to be homogeneous if Hi =H for all i = 1, . . . , n.
For instance, if the addition rule Di is merely a function of the ith patient’s
observed outcome, the addition rules are independent and identically dis-
tributed (i.i.d.). Consequently Hi =H= EDi are identical and nonrandom.
However, in clinical studies, the entire history of all previous trials provides
more information of the efficacies of the treatments. For applications of such
models, one can refer to Andersen, Faries and Tamura [1] and Bai, Hu and
Shen [6]. If the addition rules rely on all the previous outcomes, the GPU
model is no longer homogeneous. Under these circumstances, we will only
assume that Hn converges to a limit H.
In clinical investigations, a crucial element of the treatment allocation
process is the number of patients being assigned to a particular treatment.
Here, we define Nn = (Nn,1, . . . ,Nn,K). The quantity Nn,k is the number of
times a type-k particle is selected in the first n stages. In clinical trials, Nn,k
represents the number of patients assigned to treatment k among the first
n patients. Obviously,
Nn =
n∑
i=1
Xi.(1.2)
Owing to its clinical applications, the asymptotic behavior of Nn is of im-
mense importance [15]. Athreya and Karlin [2, 3] obtained the asymptotic
convergence of Yn and Nn and conjecture that Nn is asymptotically nor-
mal. This conjecture has not been solved for almost three decades due to
its mathematical complexity. A limited success was reported by Smythe [27]
who derived the asymptotic normality of Yn and Nn under the assumptions
that the eigenvalues of the generating matrix H are simple and the GPU is
homogeneous. Bai, Hu and Zhang [7] considered functional limit theorems
of Yn and Nn for K = 2. Further, Janson [17] established functional limit
theorems of Yn and Nn for the general homogeneous GPU model and the
asymptotic normality of Nn follows.
1.2. Objectives and organization of the paper. Recently, Bai and Hu [5]
established the consistency and the asymptotic normality of the GPU non-
homogeneous model. However, their theorems rely on very stringent assump-
tions which are not valid in many practical applications (illustrated in Sec-
tion 2). In this paper, we derive a sequential estimation-adjusted urn model
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(SEU) and successfully produce important asymptotic theorems related to
Yn and Nn. Our allocation scheme is suitable for many popular clinical sce-
narios. Because the proposed urn model depends on sequential estimators
of unknown parameters, we cannot use the techniques of Bai and Hu [5] to
show the asymptotic properties. Instead, we show the law of the iterated
logarithm of the estimators first and then prove the strong consistency and
asymptotic normality of the SEUs by using the results of the law of the iter-
ated logarithm. Also we obtain the asymptotic properties of the estimators
of unknown parameters.
Another important advantage of our proposed SEU model is that it can be
used to satisfy a pre-specified treatment allocation target. Different targets
might be of interest in clinical studies [25]. In fact, there is a growing interest
in target-based designs which are derived with a pre-specified allocation
target (see, e.g., [11, 12, 16, 22, 23]). Based on some optimality consideration,
a suitable allocation target, say v, is used. It will be shown later that we
are able to define an SEU model to ensure that the allocation proportion
converges to v almost surely. Illustrative examples are given in Section 4.
To summarize, the major contributions of this paper are:
(a) to propose a general nonhomogeneous GPU model (SEU) with the
addition rules utilizing sequential estimations of unknown parameters;
(b) to show strong consistency and asymptotic normality of Nn under
widely satisfied conditions and obtain a general and explicit asymptotic
variance of Nn;
(c) to state the framework of the targeting procedures of SEU when the
desired allocation proportion is pre-specified based on some optimality con-
sideration; and
(d) to illustrate with examples the applications of the SEU model in
clinical trials.
The SEU model will be described in Section 2. Asymptotic properties are
presented in Section 3. Then in Section 4, selected examples are provided
to illustrate the application of the SEU model in clinical trials. Concluding
remarks are also given. Finally, technical proofs are stated in Section 5.
2. Sequential estimation-adjusted urn model.
2.1. The SEU process. Before the outline of the SEU model, we adopt
the following assumption on patient responses. Let the responses {{ξj,k, j =
1,2, . . .}, k = 1, . . . ,K} be K independent sequences of i.i.d. random vari-
ables, and write ξj = (ξj,1, . . . , ξj,K). In clinical trial, ξi,k can only be observed
when the ith patient is assigned to treatment k, that is, when Xi,k = 1. Now,
a useful nonhomogeneous GPU model with addition rules utilizing the entire
history of the previous trials is given as follows.
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The SEU process. Let Θ = (θ1, . . . , θK) be the parameter from the dis-
tribution of the response ξn = (ξn,1, . . . , ξn,K). If the value of Θ is known, it
is natural to consider the adaptive design with addition rules D(Θ,ξn) and
generating matrices H=H(Θ) = E[D(Θ,ξn)], whose values depend on the
parameter Θ. Here, the d× d matrix H(x) is a function continuous at point
Θ, and also, as a function of x, the matrix D(x,y) = {Dij(x,y)} is continu-
ous at pointΘ for any fixed possible value y of ξn. However, Θ is usually un-
known in practice; an estimate ofΘ is therefore required. Hence, without loss
of generality, we assume Θ= E[ξn], with its estimate Θ̂n = (θˆn,1, . . . , θˆn,K),
where θˆn,k =
1+
∑n
i=1
Xi,kξi,k
1+Nn,k
, k = 1, . . . ,K. Here, adding 1 to both the nu-
merator and the denominator is only to avoid the nonsense case of 0/0.
We consider the adaptive design with adding rules Dn =D(Θ̂n−1,ξn) and
generating matrices Hn =H(Θ̂n−1) = E[Dn|Fn−1].
The above SEU model has generating matrices Hn that are not homo-
geneous. Bai and Hu [4, 5] established the consistency and asymptotic nor-
mality of centered urn compositions Yn − EYn for a wide spectrum of urn
models with generating matrices Hn satisfying the condition that
∞∑
j=1
‖Hj −H‖
j
<∞.(2.1)
Here ‖ · ‖ denotes the norm of a matrix or a vector. This condition is in
general true for practical applications and it is true for the SEU model.
Now, let us turn to the asymptotic property of Nn that is more useful but
intricate. Janson [17] gave a general result of the limiting distribution of Nn
for homogeneous urn models (cf. his Theorem 3.28). The basic technique
of Janson [17] is to embed the urn process in a continuous-time branching
process. The embedding technique was developed by Athreya and Karlin [3].
Unfortunately, this method does not work for nonhomogeneous urns. The
very recent work of Bai and Hu [5] established the asymptotic normality of
Nn − ENn for nonhomogeneous urn models when the generating matrices
Hn satisfy condition (2.1) as well as the following condition:
‖Hn − EHn‖= o(n−1/2) in L2.(2.2)
It is beyond doubt that the asymptotic distributions of Yn and Nn with
the centralization factors EYn and ENn being substituted by nv are more
realistic, because the values EYn and ENn are both unknown and computing
them is far too complex, if not infeasible. To provide a possible solution, Bai
and Hu [5] suggested that EYn and ENn can be replaced by nv if condition
(2.1) is revised to a more stringent condition:
∞∑
j=1
‖Hj −H‖√
j
<∞.(2.3)
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The above condition is too strict for usual applications. For example, condi-
tion (2.3) is not true for the SEU model. On the other hand, condition (2.1)
is satisfied with the SEU model because
H(Θ̂n−1)−H(Θ)≈
n∑
k=1
∂H(x)
∂xk
∣∣∣∣
Θ
(θˆn−1,k − θk) = o(n−1/4) a.s.
as indicated in Bai and Hu [5]. In fact, conditions (2.2) and (2.3) are not
satisfied with the SEU model because the fastest almost sure convergence
rate of ‖Hn −H‖ is O(
√
(log logn)/n ) according to the law of the iterated
logarithm and the fastest L2 convergence rate is O(
√
n ) according to the
central limit theorem. So, the general theorems of Bai and Hu [5] do not
apply here.
2.2. Targeting pre-specified limiting allocation proportions. As explained
in the Introduction, it is frequent that desired limiting allocation proportions
are given and our SEU model has the ability to target these proportions.
First, let us state the well-known results related to the convergence of Nn
and the generating matrix H (see, e.g., [4, 5, 17]). Under suitable conditions
the allocation proportion converges to a limit, that is,
Nn
n
→ v a.s.,(2.4)
where v = (v1, . . . , vK) is the left eigenvector of the (limiting) generating
matrix H with respect to its largest eigenvalue and satisfying v1+ · · ·+vK =
1, that is,
vH= λmaxv.(2.5)
To target a pre-specified allocation proportion, one needs to define the SEU
process in such a way to force the sample allocation proportion to the desired
one as a limit. To illustrate, we will take the two-treatment case with binary
responses as an example.
For a binary response (success and failure) clinical trial with two treat-
ments (1 and 2), Rosenberger et al. [26] proposed the following allocation
proportion (called the optimal allocation proportion) by considering simul-
taneously the statistical testing power for comparing the two treatments and
the failure rate of patients undergoing the two treatments,
Nn,1
n
.
=
√
p1√
p1 +
√
p2
,
Nn,2
n
.
=
√
p2√
p1 +
√
p2
.
Other allocation proportions and a general procedure to find an allocation
proportion according to an optimization criterion had been discussed by
Jennison and Turnbull [18]. When the SEU model is used to target the above
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proportion, we need to define an urn model such that v= (
√
p1√
p1+
√
p2
,
√
p2√
p1+
√
p2
)
is the eigenvector of its generating matrix H with respect to the largest
eigenvalue. Assume that the expectation of total number of balls added at
each stage is the same, say γ. Then H can be written in the following form:
H=
(
γ −α α
β γ − β
)
.(2.6)
According to (2.5), we have
α
β
=
v2
v1
=
√
p2√
p1
.
One simple solution of the above equation is α=
√
p2 and β =
√
p1. Another
obvious solution is α= v2 and β = v1. In either case, the generating matrix
is a function of p1 and p2. If p1 and p2 are known, to implement the alloca-
tion proportion, we can define an SEU model with addition rules Di ≡H.
Further, when p1 and p2 are unknown, their estimates will be employed as
instructed in the previous subsection. Examples are provided in Section 4.
3. Asymptotic properties. In this section we will study the asymptotic
properties for our SEU model. Major theorems will be given with proofs
stated in the last section. Owing to the use of estimates of the unknown
parameters, one will discover that the asymptotic variance is different from
that given in [5] and [17] and the mathematical techniques are much more
complex.
Recall that Yn and Nn are defined by (1.1) and (1.2) and H =H(Θ),
Dn =D(Θ̂n−1,ξn). To study the asymptotic properties of Yn and Nn, the
following assumptions are required.
Assumption 3.1. We assume that H1′ = γ1′, where γ > 0 and 1 =
(1, . . . ,1). Suppose H has the following Jordan decomposition:
T−1HT= γ diag[1,J2, . . . ,Js],
where Js is a νt × νt matrix, given by
Jt =

λt 1 0 . . . 0
0 λt 1 . . . 0
0 0 λt . . . 0
...
...
...
. . .
...
0 0 0 . . . λt
 .
Without loss of generality, we assume that γ = 1. Otherwise, we can consider
Yn/γ and Dn/γ, instead.
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Let v be the left eigenvector of H corresponding to its maximal eigen-
value 1 with v1′ = 1′. We may select the matrix T so that its first column
is 1′ and the first row of T−1 is v. Let λ = max{Re(λ2), . . . ,Re(λs)} and
ν =maxj{νj :Re(λj) = λ}.
Assumption 3.2. For the addition rules Dn = D(Θ̂n−1,ξn) and the
responses ξn, suppose Dij(x,y)≥ 0 is continuous at point (Θ,y0) for each
y0 and there is an r > 2 such that E‖ξ1‖r <∞ and
sup
n
E[‖Dn‖r|Fn−1]<∞ a.s.(3.1)
Assumption 3.3. For the function H(x),
H(x)−H=H(x)−H(Θ) =O(‖x−Θ‖) as x→Θ.
Assumption 3.4. For the function H(x), there is a δ > 0 such that
H(x)−H=
K∑
k=1
∂H(x)
∂xk
∣∣∣∣
x=Θ
(xk − θk) +O(‖x−Θ‖1+δ) as x→Θ.
Remark 3.1. Condition (3.1) is satisfied if we assume that E[‖D(x,ξ1)‖r]
is a continuous function of x.
Using the above notation, we shall establish the following results.
Theorem 3.1. For the SEU, suppose that Assumption 3.1 is satisfied.
If λ < 1, and Assumption 3.2 is satisfied for some r > 1, then
Yn
n
→ v and Nn
n
→ v a.s.
Theorem 3.2. For the SEU, if Assumptions 3.1–3.3 are satisfied, and
vk > 0, k = 1, . . . ,K, λ < 1, then for any κ > (1/2) ∨ λ,
n−κ(Yn − nv)→ 0 and n−κ(Nn − nv)→ 0 a.s.
Theorem 3.3. For the SEU, if Assumptions 3.1, 3.2 and 3.4 are satis-
fied, and vk > 0, k = 1, . . . ,K, λ < 1/2, then
n1/2(Yn/n− v) D→N(0,Λ†) and n1/2(Nn/n− v) D→N(0,Λ♯),
where N(0,Λ†) and N(0,Λ♯) are the normal distributions in RK with mean
zero and K × K variance–covariance matrices Λ† and Λ♯, which will be
specified by (5.24) and (5.26), respectively.
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Let H =H − 1′v and D =D(Θ,ξ1). Define Σ1 = diag(v) − v′v, Σ2 =
E[(D−H)′ diag(v)(D−H)], Σ3 = diag(v1σ21 , . . . , vKσ2k), Σ23 = E[(D−H)′×
diag(v)diag(ξ1 − Θ)], where σ2k = Var(ξi,k), k = 1,2, . . . ,K. Covariance–
variance matrices Λ† and Λ♯ are functions of H, Σ1, Σ2, Σ3 and Σ23.
Remark 3.2. If λ= 1/2, the asymptotic normalities also hold, but with
different normalizing, given by n1/2 logν−1/2 n, and different Λ† and Λ♯.
From the proof of Theorem 3.3, one also obtains the following corollary.
Corollary 3.1. For SEU, if Assumptions 3.1 and 3.2 are satisfied,
and vk > 0, k = 1, . . . ,K, λ < 1, then
n1/2(Θ̂n −Θ) D→N(0,diag(σ21/v1, . . . , σ2K/vK)),
where σ2k =Var(ξ1,k), k = 1, . . . ,K.
The next corollary provides results on a special case of SEU.
Corollary 3.2. Let ρ(x) = (ρK(x), . . . , ρK(x)) be a vector function be-
ing twice differentiable at Θ and ρk(x)> 0, h= 1, . . . ,K. Consider an adap-
tive design with addition rules Dn = 1
′ρ(Θ̂n−1), that is, ρk(Θ̂n−1) balls of
type k are added to the urn at stage n, k = 1, . . . ,K, where Θ̂n−1 is the
sample estimate of Θ which is defined as in SEU. Then
Yn
n
→ ρ(Θ) a.s., Nn
n
→ v a.s.
and
√
n
(
Yn
n
− ρ(Θ)
)
D→N(0,2Σρ),
√
n
(
Nn
n
− v
)
D→N(0,diag(v)− v′v+6Σv),
where γ =
∑
k ρk(Θ), v= ρ(Θ)/γ,
Σρ =
(
∂ρ(Θ)
∂Θ
)′
I−1(Θ)
∂ρ(Θ)
∂Θ
,
Σv =
(
∂v(Θ)
∂Θ
)′
I−1(Θ)
∂v(Θ)
∂Θ
,
I−1(Θ) = diag
(
σ21
v1
, . . . ,
σ2K
vK
)
and v(x) = ρ(x)∑
k
ρk(x)
. Here
∂ρ(Θ)
∂Θ denotes the matrix {
∂ρj (x)
∂xi
|x=Θ; i= 1, . . . ,K,
j = 1, . . . ,K}.
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4. Applications and conclusions. In this section we give some motivating
examples in order to show the applicability of our SEU model. The first one
is related to allocation schemes which aim at assigning more patients to the
better treatment. The remaining two are connected to designs with focus on
desired targets.
Example 1 ([6]). Consider a K-treatment clinical trial with binary re-
sponses. Let pk be the success probability of a patient on treatment k, and
let qk = 1 − pk be the failure probability, k = 1, . . . ,K. Bai, Hu and Shen
[6] (BHS Adaptive Design) proposed to add particles proportional to the
estimated success rates for other K − 1 treatments, when the response is
a failure on treatment k, that is, at the nth stage, a success on treatment
k generates a particle of type k, and a failure on treatment k generates
pˆn−1,j
(Mn−1−pˆn−1,k) particles of type j for all j 6= k. Here Mn−1 =
∑K
j=1 pˆn−1,j ,
pˆn−1,j =
Sn−1,j+1
Nn−1,j+1
, and Sn−1,j denotes the number of successes of treatment
j in all the Nn−1,j trials of the previous n− 1 stages, j = 1, . . . ,K. They es-
tablished the strong consistency of Yn andNn of this model. For this design,
H(x) = (hk,j(x), k, j = 1, . . . ,K), where hk,k(x) = pk and hk,j(x) = qk
xj∑
i6=k
xi
for k 6= j. Using Theorem 3.3, we can get the asymptotic normalities.
Example 2. We consider a two-treatment clinical trial with binary re-
sponses. Suppose that we want to target the optimal allocation proportion
proposed by Rosenberger et al. [26]. In (2.6), we choose α=
√
p2, β =
√
p1
and γ =
√
p1 +
√
p2. The design is defined as follows. At the nth stage, no
matter what the response of the nth patient is, we add
√
pˆn−1,1 particles of
type 1 and
√
pˆn−1,2 particles of type 2 to the urn. If 0< p1, p2 < 1, then
D(x) =H(x) =
(√
x1
√
x2√
x1
√
x2
)
→D=H=
(√
p1
√
p2√
p1
√
p2
)
.
It can be verified that
Σρ = diag
(
q1
√
p1
4(
√
p1 +
√
p2 )
,
q2
√
p2
4(
√
p1 +
√
p2 )
)
and
Σv =
1
4(
√
p1 +
√
p2 )3
(
p2q1√
p1
+
p1q2√
p2
)(
1 −1
−1 1
)
.
By Corollary 3.2, (
Yn,1
n
,
Yn,2
n
)
→ (√p1,√p2 ),(
Nn,1
n
,
Nn,2
n
)
→
( √
p1√
p1 +
√
p2
,
√
p2√
p1 +
√
p2
)
a.s.,
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n1/2
(
Yn,1
n
−√p1, Yn,2
n
−√p2
)
D→N(0,Λ†)
and
n1/2
(
Nn,1
n
−
√
p1√
p1 +
√
p2
)
D→N(0, σ2♯ ),
where
Λ† = diag
(
q1
√
p1
2(
√
p1 +
√
p2 )
,
q2
√
p2
2(
√
p1 +
√
p2 )
)
and
σ2♯ =
√
p1p2
(
√
p1 +
√
p2 )2
+
3
2(
√
p1 +
√
p2 )3
(
p2q1√
p1
+
p1q2√
p2
)
.
Example 3. We consider a two-treatment clinical trial with binary re-
sponses. Suppose that we want to target the allocation proportion (v1 =
q2
q1+q2
, v2 =
q1
q1+q2
) of the randomized play-the-winner (RPW) rule proposed
by Wei and Durham [31]. In (2.6) we choose α = v2, β = v1 and γ = 1.
Then H= (1,1)′(v1, v2). The design is defined as follows. At the nth stage,
regardless of what the response of the nth patient is, we add
qˆn−1,2
qˆn−1,1+qˆn−1,2
particles of type 1 and
qˆn−1,1
qˆn−1,1+qˆn−1,2
particles of type 2 to the urn, where
qˆn−1,k = 1− pˆn−1,k, k = 1,2. If 0< p1, p2 < 1, then
D(x) =

1− x2
(1− x1) + (1− x2)
1− x1
(1− x1) + (1− x2)
1− x2
(1− x1) + (1− x2)
1− x1
(1− x1) + (1− x2)

→D=

q2
q1+ q2
q1
q1+ q2
q2
q1+ q2
q1
q1+ q2
 ,
and H(x) = D(x), H = D. It can be verified that Σρ = Σv = q1q2(p1 +
p2)/(q1 + q2)
3(1,−1)′(−1,1). By Corollary 3.2,(
Yn,1
n
,
Yn,2
n
)
→
(
q2
q1+ q2
,
q1
q1+ q2
)
,(
Nn,1
n
,
Nn,2
n
)
→
(
q2
q1+ q2
,
q1
q1+ q2
)
a.s.,
n1/2
(
Yn,1
n
− q2
q1 + q2
,
Yn,2
n
− q1
q1+ q2
)
D→N(0, σ2† )(1,−1)
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and
n1/2
(
Nn,1
n
− q2
q1+ q2
)
D→N(0, σ2♯ ),
where
σ2† =
2q1q2(p1 + p2)
(q1 + q2)3
and σ2♯ =
q1q2[2 + 5(p1 + p2)]
(q1 + q2)3
.
The asymptotic variances are much smaller than those given by the RPW
rule when q1 + q2 is near or less than 1/2, since when q1 + q2 > 1/2, the
asymptotic variances of Yn,1/n and Nn,1/n in the RPW rule are
q1q2
[2(q1 + q2)− 1](q1 + q2)2 and
q1q2[1 + 2(p1 + p2)]
[2(q1 + q2)− 1](q1 + q2)2 ,
respectively (cf. [28]). When q1 + q2 < 1/2, the limiting distributions of Yn
and Nn in the RPW rule are unknown, and the convergence rates of the
variances are much slower. But, for the adaptive design given here, the
asymptotic normality can be evaluated according to our formula for any
0< q1, q2 < 1.
Examples 2 and 3 demonstrate the ability of the SEU model to target a
given allocation proportion. In general, we can use Corollary 3.2 to target
any desired allocation proportion. This is a useful property of our proposed
model.
The examples in this section provide illustrations of how the proposed
techniques are translated into applications in the formulation of valuable
treatment allocation schemes. We can also evaluate these schemes by re-
viewing the respective asymptotic properties of Yn and Nn.
The main contributions of this paper are in proposing the family of se-
quential estimation-adjusted urn models and showing the two important
properties of the SEU models: (i) they can be used to target any given allo-
cation proportions, and (ii) they have certain desired asymptotic properties
under some widely satisfied conditions. Based on the asymptotic results, we
are able to derive new designs which have smaller variabilities than some
traditional and popular urn models (see Example 3).
In this paper we considered the application of the SEU models in clinical
trials. The idea of using constantly updated estimators in SEU models is
novel and the SEU models can be employed in other areas. In fact, there are
abundant urn model applications where data are collected sequentially and
the consecutive estimations of unknown parameters provide better solutions
to the formulated problem.
For simplicity, the examples considered in this section are all binary re-
sponses. However, the SEU models can be applied to different types of re-
sponses. From the definition of the SEU process, the response ξn could be
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discrete or continuous. For example, we can apply the SEU model to the
case studied in Section 8 of [12]. In that case, the response is normally dis-
tributed and the target proportion is the Neyman allocation. Generally, the
assumptions in Section 3 are satisfied if the third moments of ξ and D exist
and the function H is differentiable. Therefore, the SEU model has a wide
spectrum of applications.
5. Proofs. First, we state several relevant lemmas. Recall H=H− 1′v.
Then
T−1HT= diag[0,J2, . . . ,Js].(5.1)
Lemma 5.1. Let Bn,n = I and Bn,i =
∏n
j=i+1(I + j
−1H). If two se-
quences of matrices Qn and Pn satisfy Q0 =P0 = 0 and
Qn =Pn +
n−1∑
k=0
Qk
k+ 1
H,
that is,
Qn =∆Pn +Qn−1(I+ n−1H),
where ∆Pn =Pn −Pn−1 is the difference of Pn, then
Qn =
n∑
m=1
∆PmBn,m =Pn +
n−1∑
m=1
Pm
H
m+1
Bn,m+1.(5.2)
Also,
‖Bn,m‖ ≤C(n/m)λ logν−1(n/m) for all m= 1, . . . , n,n≥ 1,(5.3)
where logx= ln(x∨ e) hereafter.
Proof. See Lemma A.1 of [16]. 
Lemma 5.2. For the SEU, if Assumption 3.2 is satisfied with some
r > 1, then Nn,k →∞, k = 1, . . . ,K, as n→∞. Furthermore, Θ̂n → Θ
a.s. whenever E‖ξ1‖ < ∞, and θˆn,k − θk = O(
√
log logNn,k
Nn,k
) a.s. whenever
E‖ξ1‖2 <∞ as n→∞, k = 1, . . . ,K.
Proof. First, notice that {‖Dn‖−E[‖Dn‖|Fn−1]} is a sequence of mar-
tingale differences with
sup
n
E[‖Dn‖|Fn−1]≤ sup
n
(E[‖Dn‖r|Fn−1])1/r <∞ a.s.
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and
∞∑
n=1
E[|‖Dn‖ − E[‖Dn‖|Fn−1]|r|Fn−1]
nr
≤
∞∑
n=1
C
nr
<∞ a.s.
by condition (3.1). According to the law of large numbers of martingales
(cf. [14]),
n∑
m=1
‖Dm‖=
n∑
m=1
E[‖Dm‖|Fm−1] + o(n) =O(n) a.s.
So, by (1.1), ‖Yn‖ ≤ ‖Y0‖ +
∑n
m=1 ‖Dm‖ = O(n) a.s. It follows that∑∞
n=1(
∑
j Yn,j)
−1 =∞ a.s. So, for each k = 1, . . . ,K,
∞∑
n=1
P(Xn,k = 1|Fn−1) =
∞∑
n=1
Yn−1,k∑
j Yn,j
≥
∞∑
n=1
Y0,k∑
j Yn,j
=∞ a.s.,
which, together with the generalized Borel–Cantelli lemmas, implies that
P(Xn,k = 1, i.o.) = 1. Then Nn,k →∞ a.s., k = 1, . . . ,K. By Lemma A.4
of [16] again, the lemma is proved. 
Now, let |Yn| = Yn1′ be the total number of balls in the urn at the
nth stage, and let Mn =
∑n
k=1∆Mk and mn =
∑n
k=1∆mk, where ∆Mk =
XkDk−E[XkDk|Fk−1] and ∆mk =Xk−E[Xk|Fk−1]. Then {(mn,Mn),Fn;
n≥ 1} is a martingale sequence. By (1.1),
Yn =Y0 +Mn +
n−1∑
m=0
Ym
|Ym|Hm+1.(5.4)
Note that v1′v= v and vH= 0. By (5.4), it follows that
Yn − nv=Mn +
n−1∑
m=0
(
Ym
|Ym| − v
)
Hm+1 +
n∑
m=1
v(Hm −H) +Y0
=Mn +
n−1∑
m=0
(
Ym
|Ym| − v
)
H+
n∑
m=1
v(Hm −H)
+
n−1∑
m=0
(
Ym
|Ym| − v
)
(Hm+1 −H) +Y0
(5.5)
=Mn +
n−1∑
m=0
(
Ym
|Ym| − v
)
H+
n∑
m=1
v(Hm −H)
+
n−1∑
m=0
(
Ym
|Ym| − v
)
(Hm+1 −H) +Y0
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=Mn +
n−1∑
m=0
Ym −mv
m+1
H+Rn,
where
Rn =
n∑
m=1
v(Hm −H) +
n−1∑
m=0
(
Ym
|Ym| − v
)(
1− |Ym|
m+1
)
H
(5.6)
+
n−1∑
m=0
(
Ym
|Ym| − v
)
(Hm+1 −H) +Y0.
Also by (1.2),
Nn − nv=mn +
n−1∑
m=0
Ym
|Ym| − nv
=mn +
n−1∑
m=0
(
Ym
|Ym| − v
)
(I− 1′v)
=mn +
n−1∑
m=0
(
Ym
m+1
− v
)
(I− 1′v)
+
n−1∑
m=0
Ym
|Ym|
(
1− |Ym|
m+ 1
)
(I− 1′v)(5.7)
=mn +
n−1∑
m=0
Ym −mv
m+1
(I− 1′v)
+
n−1∑
m=0
(
Ym
|Ym| − v
)(
1− |Ym|
m+ 1
)
(I− 1′v).
Proof of Theorem 3.1. First, note that r > 1, ‖∆mn‖ ≤ 2, and ac-
cording to (3.1),
E[‖∆Mn‖r|Fn−1]≤ 2r sup
n
E[‖Dn‖r|Fn−1] := 2rηr <∞.(5.8)
By the strong law of large numbers of martingales, we have
Mn = o(n) and mn = o(n) a.s.(5.9)
On the other hand, by Lemma 5.2 and the continuity of H(x), we have
Hn −H= o(1) a.s.(5.10)
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Note that H1′ = 0′, and Ym/|Ym| − v is bounded. From (5.6), it follows
that
Rn1
′ =
n∑
m=1
v(Hm −H)1′ +
n−1∑
m=0
(
Ym
|Ym| − v
)
(Hm+1 −H)1′ +Y01′
(5.11)
= o(n) a.s.,
which, together with (5.5) and (5.9), implies that
|Yn| − n= (Yn − nv)1′ =Mn1′ +Rn1′ = o(n) a.s.,
that is,
|Yn|
n
→ 1 a.s.(5.12)
Now, by combining (5.6), (5.10) and (5.12) it follows that
Rn = o(n) a.s.,
which, together with (5.5) and (5.9), yields
Yn − nv=
n−1∑
m=0
Ym −mv
m+1
H+ o(n) a.s.
And then by Lemma 5.1, we conclude that
Yn − nv= o(n) +
n−1∑
m=1
o(m)
m+ 1
(n/m)λ logν−1(n/m) = o(n) a.s.,
that is,
Yn
n
→ v a.s.
Finally, from (5.7) it follows that
Nn − nv= o(n) +
n−1∑
m=0
o(m)
m+ 1
+
n−1∑
m=0
(
Ym
|Ym| − v
)
o(1) = o(n) a.s.
The proof of Theorem 3.1 is complete. 
To prove Theorem 3.2, we need the following lemma.
Lemma 5.3. Under the assumptions in Theorem 3.2, we have
Θ̂n −Θ=O
(√
log logn
n
)
and Hn −H=O
(√
log logn
n
)
a.s.
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Proof. Note that by Theorem 3.1,
n
Nn,k
→ 1
vk
a.s., k = 1, . . . ,K.
So, by Lemma 5.2,
θˆn,k − θk =O
(√
log logn
n
)
a.s., k = 1, . . . ,K.
The proof is then complete by noting Assumption 3.3. 
Proof of Theorem 3.2. First, note that ‖∆mn‖ ≤ 2, (5.8) and r > 2.
By the law of the iterated logarithm of martingales, we have
Mn =O(
√
n log logn ) and mn =O(
√
n log logn ) a.s.(5.13)
By Lemma 5.3 and similarly to (5.11) we have
Rn1
′ =
n∑
m=1
O
(√
log logm
m
)
+
n−1∑
m=1
(
Ym
|Ym| − v
)
O
(√
log logm
m
)
a.s.
=O(
√
n log logn ),
which, together with (5.5), implies that
|Yn| − n=Mn1′ +Rn1′ =O(
√
n log logn ) a.s.,
that is,
|Yn|
n
− 1 =O
(√
log logn
n
)
a.s.(5.14)
And then from (5.6), it follows that
Rn =
n∑
m=1
O
(√
log logm
m
)
+
n−1∑
m=1
(
Ym
|Ym| − v
)
O
(√
log logm
m
)
a.s.
=O(
√
n log logn ).
With (5.5) and (5.13), we conclude that
Yn − nv=
n−1∑
m=0
Ym −mv
m+1
H+O(
√
n log logn ) a.s.,
which, together with Lemma 5.1, implies that
Yn − nv=
n∑
m=1
O(
√
m log logm )
m+ 1
(n/m)λ logν−1(n/m) a.s.
(5.15)
=

O(
√
n log logn ), if λ < 1/2,
O(
√
n log logn logν n ), if λ= 1/2,
O(nλ logν−1 n ), if λ > 1/2.
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Finally, by (5.7) and (5.13)–(5.15) we conclude that
Nn − nv =O(
√
n log logn ) +
n−1∑
m=0
O(‖Ym −mv‖)
m+ 1
+
n−1∑
m=1
O
(√
log logm
m
)
a.s.
=

O(
√
n log logn ), if λ < 1/2,
O(
√
n log logn logν n ), if λ= 1/2,
O(nλ logν−1 n ), if λ > 1/2.
Theorem 3.2 is proved. 
Proof of Theorem 3.3. Without loss of generality, we assume that δ
is small enough such that δ < 1/2− λ. Define
fk = v
∂H(x)
∂xk
∣∣∣∣
x=Θ
, F=
 f1/v1...
fK/vK
= (f ′1/v1, . . . , f ′K/vK)′(5.16)
and Qn = (Qn,1, . . . ,Qn,K) =
∑n
m=1∆Qm, where ∆Qm =Xm diag(ξm−Θ).
Then Qn is a martingale since ξm is independent of Xm and the σ-field
Fm−1. By Lemma 5.3 and Assumption 3.4,
v(Hn+1 −H) = (Θ̂n −Θ)(f ′1 , . . . , f ′K)′ +O(‖Θ̂n −Θ‖1+δ)
= (Θ̂n −Θ)(f ′1 , . . . , f ′K)′ + o(n−1/2−δ/3) a.s.
Also, by Theorem 3.2,Qn =O(
√
n log logn ) a.s. and θˆn,k =
1+
∑n
m=1
Xm,kξm,k
1+Nn,k
,
k = 1, . . . ,K, we have
θˆn,k − θk = n
Nn,k + 1
1
n
(Qn,k +1− θk)
=
1
vk
1
n
Qn,k +
(
n
Nn,k +1
− 1
vk
)
1
n
Qn,k +
1− θk
Nn,k + 1
=
1
vk
1
n
Qn,k + o(n
κ−1)O(n−1/2
√
log logn ) +O
(
1
n
)
=
1
vk
1
n
Qn,k + o(n
−1/2−δ) a.s.
It follows that
v(Hn+1 −H) = 1
n
QnF+ o(n
−1/2−δ/3) a.s.(5.17)
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Now, from (5.6), (5.17), Theorem 3.2 and Lemma 5.3 it follows that
Rn =
n∑
m=1
v(Hm −H) +
n−1∑
m=1
o((m−1+κ)2)
+
n−1∑
m=1
o(m−1+κ)O
(√
log logm
m
)
=
n∑
m=1
1
m
QmF+ o(n
1/2−δ/3) a.s.
So, by (5.5),
Yn − nv=Mn +
n∑
m=1
1
m
QmF+
n−1∑
m=0
Ym −mv
m+ 1
H
(5.18)
+ o(n−1/2−δ/3) a.s.
Let U0 = 0 and
Un =Mn +
n∑
m=1
1
m
QmF+
n−1∑
m=0
Um
m+1
H.
Then
Yn − nv−Un =
n−1∑
m=0
Ym −mv−Um
m+1
H+ o(n1/2−δ/3) a.s.
By Lemma 5.1, it follows that
Yn − nv=Un +
n∑
m=1
o(m−1/2−δ/3)
(
n
m
)λ
logν−1
(
n
m
)
(5.19)
=Un + o((n
1/2−δ/4)∨ (nλ logν−1 n)) a.s.
On the other hand, by (5.2),
Un =
n∑
m=1
(
∆Mm +
1
m
QmF
)
Bn,m
=
n∑
m=1
∆MmBn,m+
n∑
m=1
∆QmF
n∑
j=m
(
1
j
Bn,j
)
.
Also, by (5.7) and Theorem 3.2,
Nn − nv =mn +
n−1∑
m=0
Ym −mv
m+1
(I− 1′v) +
n−1∑
m=1
o((m−1+κ)2)
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=mn +
n−1∑
m=0
Um
m+ 1
(I− 1′v)
+ o((n1/2−δ/4)∨ (nλ logν−1 n)) + o(n1/2−δ)
=mn +
n−1∑
m=1
∆Mm
(
n−1∑
i=m
1
i+1
Bi,m
)
(I− 1′v)(5.20)
+
n−1∑
m=1
∆QmF
(
n−1∑
i=m
i∑
j=m
1
(i+1)j
Bi,j
)
(I− 1′v)
+ o((n1/2−δ/4)∨ (nλ logν−1 n))
:=Vn + o((n
1/2−δ/4)∨ (nλ logν−1 n)) a.s.
So, to show the asymptotic normalities of Yn and Nn, it suffices to show
the asymptotic normalities of Un andVn. Write B
(1)
n,m =
∑n
j=m
Bn,j
j , B
(2)
n,m =∑n−1
i=m
Bi,m
i+1 andB
(3)
n,m =
∑n−1
i=m
∑i
j=m
Bi,j
(i+1)j , where
∑k
j=k+1(·) = 0 and soB(i)n,n =
0, i= 1,2,3. Then
Un =
n∑
m=1
(∆MmBn,m +∆QmFB
(1)
n,m),
(5.21)
Vn =
n∑
m=1
(∆mm +∆MmB
(2)
n,m(I− 1′v) +∆QmFB(3)n,m(I− 1′v)).
Note that Un and Vn are sums of martingale differences. We will use the
central limit theorem for martingale (cf. [14]) to prove our result. According
to (5.8),
1
nr/2
n∑
m=1
{E[‖∆MmBn,m +∆QmFB(1)n,m‖r|Fm−1]
+ E[‖∆mm +∆MmB(2)n,m(I− 1′v)
+∆QmFB
(3)
n,m(I− 1′v)‖r|Fm−1]}
≤ C
nr/2
n∑
m=1
((
n
m
)λ
logν−1
n
m
)r
(5.22)
× E[‖∆mm‖r + ‖∆Mm‖r + ‖∆Qm‖r|Fm−1]
≤ C
nr/2
n∑
m=1
((
n
m
)λ
logν−1
n
m
)r
{1 + 2rηr + E‖ξm‖r}
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≤ Cn
nr/2
∫ n
1
yλr−2 log(ν−1)r y dy→ 0 a.s. as n→∞,
that is, the Lindberg condition is satisfied. Finally, it is enough to calcu-
late the asymptotic (conditioned) variance–covariance matrices of Un and
Vn. Recall Σ1 = diag(v) − v′v, Σ2 = E[(D −H)′ diag(v)(D −H)], Σ3 =
diag(v1σ
2
1 , . . . , vKσ
2
k), Σ23 = E[(D −H)′ diag(v)diag(ξ1 −Θ)], where D =
D(Θ,ξ1) and σ
2
k =Var(ξi,k), k = 1,2, . . . ,K. Notice (5.8) and the continuity
of the functions D(·,ξn) and H(·). Then by Theorem 3.1, Assumption 3.2
and Lemma 5.2, we have
Var[∆Mn|Fn−1]
= E
[
D′n diag
(
Yn−1
|Yn−1|
)
Dn|Fn−1
]
−H′n
Y′n−1
|Yn−1|
Yn−1
|Yn−1|Hn
= E
[
(Dn −Hn)′ diag
(
Yn−1
|Yn−1|
)
(Dn −Hn)|Fn−1
]
+H′n
[
diag
(
Yn−1
|Yn−1|
)
− Y
′
n−1
|Yn−1|
Yn−1
|Yn−1|
]
Hn
→Σ2 +H′Σ1H a.s.,
Var[∆mn|Fn−1]
= diag
(
Yn−1
|Yn−1|
)
− Y
′
n−1
|Yn−1|
Yn−1
|Yn−1| →Σ1 a.s.,
Var[∆Qn|Fn−1]
= E[diag(Xn,1(ξn,1 − θ1)2, . . . ,Xn,K(ξn,K − θK)2)|Fn−1]
= diag
(
σ21Yn−1,1
|Yn−1| , . . . ,
σ2KYn−1,K
|Yn−1|
)
→Σ3 a.s.,
Cov[(∆mn,∆Mn)|Fn−1]
=
[
diag
(
Yn−1
|Yn−1|
)
− Y
′
n−1
|Yn−1|
Yn−1
|Yn−1|
]
Hn
→Σ1H a.s.,
Cov[(∆mn,∆Qn)|Fn−1]
= E[(Xn − E[Xn|Fn−1])′Xn diag(ξn −Θ)|Fn−1]
= 0
and
Cov[(∆Mn,∆Qn)|Fn−1]
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= E
[
D′n diag
(
Yn−1
|Yn−1|
)
diag(ξn −Θ)|Fn−1
]
→Σ23 a.s.
So,
Var[(∆mn,∆Mn −∆mnH,∆Qn)|Fn−1]
(5.23)
→
Σ1 0 00 Σ2 Σ23
0 Σ′23 Σ3
 a.s.
By noting (5.21),
HBn,m =Bn,mH and H(I− 1′v) =H,
we can write
Un =U
(1)
n H+U
(2)
n +U
(3)
n
and
Vn =V
(1)
n +V
(2)
n (I− 1′v) +V(3)n (I− 1′v),
where
U(1)n =
n∑
m=1
∆mmBn,m,
U(2)n =
n∑
m=1
(∆Mm −∆mnH)Bn,m,
U(3)n =
n∑
m=1
∆QmFB
(1)
n,m,
V(1)n =
n∑
m=1
∆mm +
n−1∑
m=1
∆mmHB
(2)
n,m(I− 1′v)
= ∆mn +
n−1∑
m=1
∆mm(B
(2)
n,mH+ I)
= ∆mn +
n−1∑
m=1
∆mmBn,m =U
(1)
n ,
V(2)n =
n∑
m=1
(∆Mm −∆mmH)B(2)n,m,
V(3)n =
n∑
m=1
∆QmFB
(3)
n,m.
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Then by (5.23),
Var(U(1)n |) =
n∑
m=1
E[(∆mmBn,m)
′∆mmBn,m|Fm−1]
=
n∑
m=1
B
′
n,m(Σ1 + o(1))Bn,m
=
∫ n
1
(
n
x
)H′
Σ1
(
n
x
)H
dx+ o(1)
n∑
m=1
(
n
m
)2λ
log2ν−2
(
n
m
)
= n
∫ 1
1/n
(
1
x
)H′
Σ1
(
1
x
)H
dx+ o(n)
= n
∫ 1
0
(
1
x
)H′
Σ1
(
1
x
)H
dx+ o(n) := nΛ†1 + o(n) a.s.,
where aH is defined to be eH lna =
∑∞
j=0
(lna)j
j! H
j
. Here we use Var(·|) to
denote the sum of conditional variance–covariance matrices of related mar-
tingale differences, and Cov{·, ·|} is defined similarly. Also,
Var(U(2)n |) =
n∑
m=1
B
′
n,m(Σ2 + o(1))Bn,m
= n
∫ 1
0
(
1
x
)H′
Σ2
(
1
x
)H
dx+ o(n) := nΛ†2 + o(n) a.s.,
Var(U(3)n |) =
n∑
m=1
(B(1)n,m)
′
F′(Σ3 + o(1))FB(1)n,m
=
∫ n
1
dx
[∫ n
x
1
y
(
n
y
)H
dy
]′
F′Σ3F
[∫ n
x
1
y
(
n
y
)H
dy
]
+ o(n)
= n
∫ 1
0
dx
[∫ 1
x
1
y
(
1
y
)H
dy
]′
F′Σ3F
[∫ 1
x
1
y
(
1
y
)H
dy
]
+ o(n)
:= nΛ†3 + o(n) a.s.,
Cov{U(1)n ,U(2)n |}=
n∑
m=1
E[(∆mmBn,m)
′(∆Mm −∆mnH)Bn,m|Fm−1]
= o(n) a.s.,
Cov{U(1)n ,U(3)n |}= 0 a.s.
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and
Cov{U(2)n ,U(3)n |}=
n∑
m=1
B
′
n,m(Σ23 + o(1))FB
(1)
n,m
=
∫ n
1
dx
(
n
x
)H′
Σ23F
[∫ n
x
1
y
(
n
y
)H
dy
]
+ o(n)
= n
∫ 1
0
dx
(
1
x
)H′
Σ23F
[∫ 1
x
1
y
(
1
y
)H
dy
]
+ o(n)
:= nΛ†23 + o(n) a.s.
Note that ‖aH‖ ≤ Caλ logν−1 a for a ≥ 1. The above integrals are well de-
fined. It follows that
n−1Var(Un|)→H′Λ†1H+Λ†2 +Λ†3 +Λ†23 + (Λ†23)′ :=Λ†.(5.24)
And then by the central limit theorem for martingales (cf. [14])
n−1/2Un
D→N(0,Λ†).(5.25)
Similarly,
Var(V(1)n |) = Var(U(1)n |) = nΛ†1 + o(n) a.s.,
Var(V(2)n |) =
n∑
m=1
(B(2)n,m)
′(Σ2 + o(1))B(2)n,m
=
∫ n
1
dx
[∫ n
x
1
y
(
y
x
)H
dy
]′
Σ2
[∫ n
x
1
y
(
y
x
)H
dy
]
+ o(n)
= n
∫ 1
0
dx
[∫ 1
x
1
y
(
y
x
)H
dy
]′
Σ2
[∫ 1
x
1
y
(
y
x
)H
dy
]
+ o(n)
:= nΛ♯2 + o(n) a.s.,
Var(V(3)n |) =
n∑
m=1
(B(3)n,m)
′
F′(Σ3 + o(1))FB(3)n,m
=
∫ n
1
dx
[∫ n
x
dy
∫ y
x
du
1
yu
(
y
u
)H]′
×F′Σ3F
[∫ n
x
dy
∫ y
x
du
1
yu
(
y
u
)H]
+ o(n)
= n
∫ 1
0
dx
[∫ 1
x
dy
∫ y
x
du
1
yu
(
y
u
)H]′
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×F′Σ3F
[∫ 1
x
dy
∫ y
x
du
1
yu
(
y
u
)H]
+ o(n)
:= nΛ♯3 + o(n) a.s.,
Cov{V(1)n ,V(2)n |}= o(n) a.s., Cov{V(1)n ,V(3)n |}= 0 a.s.
and
Cov{V(2)n ,V(3)n |}
=
n∑
m=1
(B(2)n,m)
′(Σ23 + o(1))FB(3)n,m
=
∫ n
1
dx
[∫ n
x
1
y
(
y
x
)H
dy
]′
F′Σ23F
[∫ n
x
dy
∫ y
x
du
1
yu
(
y
u
)H]
+ o(n)
= n
∫ 1
0
dx
[∫ 1
x
1
y
(
y
x
)H
dy
]′
F′Σ23F
[∫ 1
x
dy
∫ y
x
du
1
yu
(
y
u
)H]
+ o(n)
:= nΛ♯23 + o(n) a.s.
It follows that
n−1Var(Vn|)→Λ†1 + (I− v′1)Λ♯2(I− 1′v)
+ (I− v′1)(Λ♯3 +Λ♯23 + (Λ♯23)′)(I− 1′v)(5.26)
:= Λ♯ a.s.
And then by the central limit theorem for martingales (cf. [14]),
n−1/2Vn
D→N(0,Λ♯).(5.27)
Combining (5.19), (5.20), (5.25) and (5.27), we complete the proof of The-
orem 3.3. 
Proof of Corollary 3.1. Note that Qn =O(n
1/2) in L2. By Theo-
rem 3.1, we have
θˆn,k − θk = 1
vk
1
n
Qn,k +
(
n
Nn,k + 1
− 1
vk
)
1
n
Qn,k +
1− θk
Nn,k + 1
=
1
vk
1
n
Qn,k + o(1)O(n
−1/2) +O
(
1
n
)
=
1
vk
1
n
Qn,k + o(n
−1/2) in probability, k = 1, . . . ,K.
On the other hand,
n−1/2Qn
D→N(0,Σ3).
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The result follows. 
Proof of Corollary 3.2. Now, H1′ = γ, we shall consider Yn/γ
instead ofYn, andD(x)/γ instead ofD(x). Notice thatD(x)/γ ≡H(x)/γ =
1′ρ(x)/γ, and then Σ2 =Σ23 = 0. It follows that Λ
†
2 =Λ
†
23 =Λ2
♯ =Λ♯23 = 0,
and then Λ† = (H/γ)′Λ†1(H/γ)+Λ
†
3 and Λ
♯ =Λ†1+(I−v′1)Λ♯3(I−1′v) by
(5.25) and (5.26). Also, H/γ = 1′v and H=H/γ − 1′v= 0. Thus
Λ
†
1 =
∫ 1
0
(
1
x
)0
Σ1
(
1
x
)0
dx=Σ1 = diag(v)− v′v,
(H′/γ)Λ†1(H/γ) = 0,
Λ
†
3 =
∫ 1
0
dx
[∫ 1
x
dy
y
]2
(F/γ)′Σ3(F/γ) = 2(F/γ)′Σ3(F/γ)
and
Λ
♯
3 =
∫ 1
0
dx
[∫ 1
x
dy
y
∫ y
x
du
u
]2
(F/γ)′Σ3(F/γ)
=
∫ 1
0
1
4
(lnx)4(F/γ)′Σ3(F/γ)dx= 6(F/γ)′Σ3(F/γ).
Notice that v∂H(x)/∂xk = ∂ρ(x)/∂xk . It is easy to see that
(F/γ)′Σ3(F/γ) =
1
γ2
(
∂ρ(Θ)
∂Θ
)′
I−1(Θ)
∂ρ(Θ)
∂Θ
=Σρ/γ
2.
Hence Λ† = 2Σρ/γ2 and Λ♯ =Λ
†
1+6(I−v′1)Σρ(I−1′v)/γ2. By Theorems
3.1 and 3.3, we conclude that
Yn/γ
n
→ v a.s., Nn
n
→ v a.s.
and
√
n
(
Yn/γ
n
− v
)
D→N(0,2Σρ/γ2),
√
n
(
Nn
n
− v
)
D→N(0,Λ♯).
Finally, notice that ρ(x) = ρ(x)1′v(x). We have
∂ρ(Θ)
∂Θ
(I− 1′v) = ∂ρ(Θ)1
′
∂Θ
v(I− 1′v) + γ ∂v(Θ)
∂Θ
(I− 1′v)
= 0+ γ
∂v(Θ)
∂Θ
− γ ∂v(Θ)1
′
∂Θ
v= γ
∂v(Θ)
∂Θ
.
The proof is now complete. 
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Remark 5.1. One can also show that n−1Cov{Un,Vn|} →Λ†♯ a.s. for
some Λ†♯. So,
n1/2(Yn/n− v,Nn/n− v) D→N
(
0,
(
Λ† Λ†♯
(Λ†♯)′ Λ♯
))
.
Actually, with a more careful but complex proof similar to that in [16], one
can show that the process n−1/2(Y[nt]− [nt]v,N[nt]− [nt]v) is weakly conver-
gent to a 2K-dimensional Gaussian process (G1(t),G2(t)) in the Skorohod
topology, where G1(t) is the solution of
dG1(t) = dW1(t)H+ dW2(t) +
W3(t)
t
Fdt+
G1(t)
t
Hdt,
G1(0) = 0,
(W1(t),W2(t),W3(t)) is a 3K-dimensional Brownian motion with variance–
covariance matrix defined in (5.23) and
G2(t) =W1(t) +
∫ t
0
G1(s)
s
ds(I− 1′v).
Furthermore, we also have
n−1Cov{Qn,Un|}→ (Σ′23 +Σ3)(I−H)−1 a.s.
and
n−1Cov{Qn,Vn|} → (Σ23′ +Σ3)(I−H)−1(I− 1′v) a.s.
This shows that the joint distribution of n1/2(Θ̂n −Θ), n1/2(Yn/n − v)
and n1/2(Nn/n − v) converges to a mean-zero 3K-dimensional Gaussian
distribution.
If λ = 1/2, one also can show that (5.22) holds with (n log2ν−1 n)1+δ/2
replacing nr/2, and that (n log2ν−1 n)−1Var{(Un,Vn)|} converges to a 2d×
2d matrix. This implies that the asymptotic normalities of Yn and Nn also
hold.
Remark 5.2. Λ† and Λ♯ can be derived. As an example, we provide
details to derive the second part of Λ♯, that is, (I− v′1)Λ♯2(I− 1′v). Other
similar terms can be derived in the same fashion. Write T= (1′,T2, . . . ,Ts)
and T∗(I− v′1)Λ♯2(I− 1′v)T= (Σgh, g, h= 1, . . . , s). Note that
T∗Λ♯2T
=
∫ 1
0
dx
[∫ 1
x
1
y
(
y
x
)diag[0,J∗2,...,J∗s ]
dy
]
T∗Σ2T
[∫ 1
x
1
y
(
y
x
)diag[0,J2,...,Js]
dy
]
=
∫ 1
0
dx
[∫ 1
x
diag
[
1,
1
y
(
y
x
)J∗2
, . . . ,
1
y
(
y
x
)J∗s]
dy
]
T∗Σ2T
×
[∫ 1
x
diag
[
1,
1
y
(
y
x
)J2
, . . . ,
1
y
(
y
x
)Js]
dy
]
.
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So,
T∗(I− v′1)Λ2♯(I− 1′v)T
= diag(0,1, . . . ,1)T∗Λ♯2Tdiag(0,1, . . . ,1)
=
∫ 1
0
dx
[∫ 1
x
diag
[
0,
1
y
(
y
x
)J∗2
, . . . ,
1
y
(
y
x
)J∗s]
dy
]
T∗Σ2T
×
[∫ 1
x
diag
[
0,
1
y
(
y
x
)J2
, . . . ,
1
y
(
y
x
)Js]
dy
]
.
Also, (
y
x
)Jt
=
(
y
x
)λt νt−1∑
a=0
Jˆat
a!
loga
(
y
x
)
,
where
Jˆt =

0 1 0 . . . 0
0 0 1 . . . 0
...
...
...
. . .
...
0 0 0 . . . 1
0 0 0 . . . 0
 , Jˆ2t =

0 0 1 . . . 0
0 0 0 . . . 0
...
...
...
. . .
...
0 0 0 . . . 0
0 0 0 . . . 0
 , . . . .
So, Σ11 = 0. For g,h= 2, . . . , s, Σ
∗
1g =Σg1 = 0,
Σgh =
∫ 1
0
dx
[∫ 1
x
1
y
(
y
x
)J∗g
dy
]
T∗gΣ2Th
[∫ 1
x
1
y
(
y
x
)Jg
dy
]
,
and the (a, b)-element of Σgh is
a−1∑
a′=0
b−1∑
b′=0
[T∗gΣiTh]a−a′,b−b′
×
∫ 1
0
[∫ 1
x
(y/x)λ¯g
a′!y
loga
′
(
y
x
)
dy
][∫ 1
x
(y/x)λh
b′!y
logb
′
(
y
x
)
dy
]
dx
=
a−1∑
a′=0
b−1∑
b′=0
[T∗gΣ2Th]a−a′,b−b′
×
[
a′∑
l=0
(b′ + l)!
l!b′!
(1− λ¯g)−(a′−l+1)(1− λ¯g − λh)−(b′+l+1)
+
b′∑
l=0
(a′ + l)!
l!a′!
(1− λ¯g)−(b′−l+1)(1− λ¯g − λh)−(a′+l+1)
]
,
where [T∗gΣ2Th]a′,b′ is the (a′, b′)-element of the matrix [T∗gΣ2Th].
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